Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 5 min read

What does the research say about thermogenesis?

Thermogenesis research spans diet-induced energy expenditure, adipose browning, and pharmacological targets. This page summarises the evidence from registered trials and preclinical studies, noting where findings are ani

peptides-pro Editorial

What does the research say about thermogenesis?

Thermogenesis is the production of heat through metabolic processes. In research contexts, it is commonly divided into shivering and non-shivering thermogenesis, with the latter including diet-induced thermogenesis (DIT) and adaptive thermogenesis in brown adipose tissue (BAT) and beige adipocytes. The term 'thermogenesis' has no single chemical formula or molecular weight; it describes a physiological outcome rather than a discrete compound. Identifiers in the literature refer to specific proteins, receptors, or interventions that modulate thermogenic pathways.

Much of the work centres on adrenergic signalling and the uncoupling protein 1 (UCP1) pathway in adipose tissue, as well as on incretin receptor families such as GLP-1R and GIPR that influence energy balance.

Research Studies

FSTL1 and white adipose tissue browning in male mice

Follistatin-like 1 (FSTL1) is an adipokine implicated in adipose tissue function. In male mice at ambient room temperature, FSTL1 overexpression induced white adipose tissue (WAT) browning, enhanced energy metabolism, and promoted glucose uptake. Overexpression specifically in WAT prevented metabolic dysfunction in mice with diet-induced obesity, while FSTL1 deficiency led to cold intolerance and increased susceptibility to obesity. The authors noted that FSTL1 cannot directly induce browning, suggesting an indirect mechanism involving adipose-sympathetic nerve crosstalk [2]. These findings are animal-only.

Sulforaphane and obesity-related metabolic dysfunction

Sulforaphane, an isothiocyanate derived from broccoli and other cruciferous vegetables, has been evaluated in a narrative review for its antioxidant, anti-inflammatory, and metabolic regulatory properties. The review critically assesses mechanistic insights, preclinical evidence, and clinical perspectives in obesity and obesity-related metabolic dysfunction [3]. The evidence base includes in vitro and animal studies, with clinical data still limited.

GIPR agonism and antagonism in obesity pharmacotherapy

GLP-1 receptor agonists produce clinically meaningful weight loss and improvements in glycemic control, but their efficacy is constrained by dose-limiting gastrointestinal adverse effects. Dual GLP-1R/GIPR agonists have shown clinical success, and research continues into GIPR antagonism as an alternative approach. The review discusses the need to expand the therapeutic window by dissociating metabolic efficacy from aversive side effects [4]. This work synthesises clinical and preclinical findings.

Systemic vibration therapy and thermogenesis in adults with obesity

A registered clinical trial evaluated the effects of systemic vibration therapy (SVT) on thermogenesis, cardiovascular parameters, endocrine-inflammatory markers, and physical-functional performance in adults with obesity. The study compared vertical and side-alternating vibrating platforms to a placebo group (platform turned off but simulating sound) to assess changes in these health parameters [5]. Results are not yet available in the evidence block.

Increasing caloric intake and diet-induced thermogenesis

Diet-induced thermogenesis (DIT) refers to the energy used to eat, absorb, and process nutrients. A clinical trial investigated how changing the balances of protein, fat, carbohydrates, and total calories affect DIT in healthy adults aged 18 to 60 years. Participants stayed in a clinic for about 35 days and received eight different diets, including seven test diets [6]. This study is ongoing or completed; results are not detailed in the evidence block.

Postprandial gut hormone responses and meal-induced thermogenesis in type 1 diabetes

A study compared postprandial responses to a test meal between subjects with type 1 diabetes and healthy controls, focusing on gut hormone levels, meal-induced thermogenesis, hunger and satiety perception, and other metabolic parameters [7]. This trial provides a model for understanding thermogenesis in a diabetes context.

Long-term weight loss and meal-induced thermogenesis

Another study examined postprandial gut-hormone secretion, meal-induced thermogenesis, fasting plasma metabolomic/lipidomic and cardiovascular indices among surgically managed obese individuals compared to conservatively managed obese patients in the long term [8]. This work addresses how weight loss interventions affect thermogenic responses.

Mazdutide in type 2 diabetes with nonalcoholic fatty liver disease

A multicenter, prospective, randomized controlled trial is evaluating the efficacy and safety of switching to mazdutide therapy in Chinese patients with type 2 diabetes mellitus (T2DM) and moderate-to-severe nonalcoholic fatty liver disease (NAFLD) who have achieved glycemic control. The study notes that Chinese T2DM patients are susceptible to visceral fat accumulation, and coexisting moderate-to-severe fatty liver elevates liver-related and all-cause risks [1]. Thermogenesis is not the primary endpoint, but the trial contributes to understanding metabolic interventions in this population.

Reference-only findings on thermogenesis

Several studies provide additional context. Canagliflozin promoted 3T3-L1 preadipocyte differentiation and enhanced lipid mobilization and thermogenesis in a manner dependent on AMPK/autophagy [9]. Adipose stem cell-targeted local delivery of forskolin induced de novo beige adipogenesis and adipose tissue browning in a preclinical model [10]. Epigallocatechin gallate (EGCG) triggered a BAT-independent thermogenic switch and remodelled the immune microenvironment in subcutaneous adipose tissue [11]. In diabetic rats, time-restricted feeding and high-intensity interval training affected thermogenesis-related protein abundance in white adipose tissue [12]. These findings are from in vitro or animal studies and are reported here as facts from the respective papers.

If you are reading this for personal health reasons

The compounds and interventions discussed on this page are sold for laboratory research purposes only. We do not provide dosing, medical guidance, or recommendations for personal use. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

WhatsApp